ExLibris header image
SFX Logo
Title: Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Vidali, G yr:1978


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Manon, L. "Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways." Pharmacological research 129 (2018): 337-356. Link to SFX for this item
2. Ryu Hyun-Wook, R. "A potent hydroxamic acid-based, small-molecule inhibitor A452 preferentially inhibits HDAC6 activity and induces cytotoxicity toward cancer cells irrespective of p53 status." Carcinogenesis 39.1 (2018): 72-83. Link to SFX for this item
3. Blackburn, C. "Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform." Journal of medicinal chemistry 56.18 (2013): 7201-7211. Link to Full Text for this item Link to SFX for this item
4. Choi, E. "Structure and property based design, synthesis and biological evaluation of γ-lactam based HDAC inhibitors." Bioorganic and medicinal chemistry letters 21.4 (2011): 1218-1221. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.